Scb Valleylab Force Fx Interface Unit
Karl Storz Endoscopy-America
FDA Clearance Information
The scb Valleylab Force FX Interface Unit was cleared by the FDA through the 510k pathway on October 25, 2004. It is manufactured by Karl Storz Endoscopy-America and classified as a Class 2 device.
What It Is
FDA-Cleared Indications
- Use as an interface component with compatible electrosurgical equipment according to the cleared system labeling.
- The FDA summary available for 510(k) K041912 does not specify a standalone indication for treating tumors.
Clinical Applications
- Connecting or interfacing compatible electrosurgical equipment during procedures.
- Supporting operation of an electrosurgical system when used according to the manufacturer’s instructions.
- Use in hospital or surgical-center settings as part of a compatible electrosurgical setup.
Practical Considerations
- Confirm compatibility with the specific electrosurgical generator, cables, accessories, and other system components before use.
- This interface unit should not be treated as a standalone tumor-ablation device unless the complete system labeling specifically supports that use.
- Follow the manufacturer’s instructions for installation, configuration, inspection, cleaning, and electrical safety checks.
- The available FDA record does not establish MRI safety; do not bring the device into an MRI environment unless its labeling specifically permits it.
- Use only by trained personnel familiar with electrosurgical equipment and the risks of unintended burns, electrical injury, interference, or equipment malfunction.
Frequently Asked Questions
What is scb Valleylab Force FX Interface Unit used for?
It is used for tumor ablation procedures, providing precise control of electrical energy delivery during surgery.
What specialties typically use this device?
Surgeons and interventional radiologists, particularly in surgical oncology, commonly use this device.
What are the FDA-cleared indications?
The device is cleared for use in tumor ablation procedures, targeting tumors accessible via electrosurgical techniques.